Credit: Medtronic. The Simplicity Spyral RDN system is designed to lower BP by delivering radiofrequency energy through the wall of the renal artery to denervate the kidney from sympathetic nerve ...
Add Yahoo as a preferred source to see more of our stories on Google. "I had the pleasure to work with Michelle on Spyral. I never thought...," Hutchins said before taking a moment to compose herself.
Patients treated with RDN experienced a 24-hour ambulatory systolic blood pressure reduction of 12.1mmHg. Credit: ABO PHOTOGRAPHY / Shutterstock. · Medical Device Network · ABO PHOTOGRAPHY / ...
DUBLIN - Medtronic plc today announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a unique, phased clinical program studying renal denervation in uncontrolled hypertension. This ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Medtronic (NYSE:MDT) today reported new clinical findings supporting its Symplicity Spyral renal denervation (RDN) system.
DUBLIN and CHICAGO, Nov. 7, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the six-month results from the full cohort of the SPYRAL HTN-ON MED ...
Please provide your email address to receive an email when new articles are posted on . Catheter-based renal denervation lowered BP in hypertensive patients not treated with antihypertensive ...
CHICAGO, IL—In the expanded SPYRAL HTN-ON MED trial, renal denervation with the Symplicity Spyral multielectrode catheter (Medtronic) failed to meet its primary endpoint in terms of blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results